Four years of tenofovir monotherapy for NUC naïve field practice European patients suppresses HBV replication in most patients with a favorable renal safety profile but does not prevent HCC in patients with or without cirrhosis
Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), M. Colombo(University of Milan), E. Minola(Humanitas Gavazzeni), Giuliano Rizzardini, G. Bellati(Fondazione Ricerca Molinette), M. Andreoletti(Alessandro Manzoni Hospital), Mauro Viganò(Ospedale San Giuseppe), Andrea Vavassori(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alberto Colombo(Ospedale Sant'Anna), George Papatheodoridis(National and Kapodistrian University of Athens), Ramazan Idılman(Ankara University), O. Fracassetti(Azienda Ospedaliera Treviglio), Mario Strazzabosco(Smilow Cancer Hospital), S. Zaltron(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Rafael Esteban(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), María Rízzí(University of Bergamo), G. Gubertini, Marı́a Buti(Vall d'Hebron Hospital Universitari), Giuliana Cologni(University of Bergamo), M. Vinci(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Giancarlo Spinzi(Ospedale Valduce), Francesco Castelli(University of Brescia), Federica Invernizzi(University of Milan), L. Pasulo(Ospedale Papa Giovanni XXIII), M. Fasano(University of Bari Aldo Moro), Alessia Giorgini(Università Cattolica del Sacro Cuore), N. Terreni(Ospedale Valduce), Sílvia Colombo(Azienda Ospedaliera Treviglio), Andrea Salmi(Fondazione Poliambulanza Istituto Ospedaliero), Antigoni Margariti(Hippocration General Hospital), Elena Angeli(Luigi Sacco Hospital), Massimo Zuin(AOL (United States)), Agostino Colli(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), F. Facchetti(University of Milan), Teresa Santantonio(Ospedali Riuniti di Foggia), S. Fagiuoli(Ospedale Papa Giovanni XXIII), Cihan Yurdaydın(Ankara University), Savino Bruno(Humanitas University), Maria Grazia Rumi(University of Milan), L Belli(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), P. Del Poggio, G. Mangia(University of Milan), C. Magni(ASST Fatebenefratelli Sacco), M. Milanese(Azienda Ospedaliera San Gerardo), R. Soffredini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 23
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484